SM

Sylvain Mandouze

Project Director at Ramsay Santé

Sylvain Mandouze has a diverse work experience spanning multiple industries and roles. Sylvain is currently working at Ramsay Santé as a Project Director, responsible for implementing and managing the strategic plan "Yes We Care 2025". Sylvain is also serving as the Chief of Staff, supporting the CEO in various activities. Prior to Ramsay Santé, Sylvain worked as a Senior Associate at Strategy&, part of the PwC network for six years. Sylvain also has experience in project management and product development at HID Global, as well as consultancy roles at MEOTEC, Alstom Power, and AGC. Sylvain started their career as an R&D Engineer at Eramet and later at Henkel.

Sylvain Mandouze has a diverse education history in various fields. Sylvain started their education at Chimie ParisTech - PSL from 2006 to 2009, where they obtained a Diplôme d'ingénieur in Chimie. Following that, they attended ISAE-SUPAERO from 2009 to 2010, where they earned a Mastère Spécialisé in Management de Grands Projets. Later, in 2010-2011, they pursued their education at HEC Paris, completing another Mastère Spécialisé, this time in Management de Grands Projets as well. Additionally, Sylvain Mandouze obtained a certification, CPIM Part 1, from APICS in November 2017.

Location

Paris, France

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Ramsay Santé

1 followers

After the acquisition of the Capio Group in 2018, Ramsay Santé has become Europe's leading private hospital and primary care companies. The group now has 36,000 employees and works with nearly 8,600 private practitioners. Present in 5 countries, France, Sweden, Norway, Denmark and Italy, the group treats more than 7 million patients per year in its 350 establishments. In hospitalization, Ramsay Santé offers almost all medical and surgical treatments in three business lines: Medicine-Surgery-Obstetrics (MCO), Follow-up and Rehabilitation Care (SSR) and Mental Health. Wherever it is present, the group participates in public health service missions and in the health network of the country, as in Sweden where the group has more than a hundred local health centres. The quality and safety of care is the group's priority in all the countries where it operates. This is why the group is today one of the references in modern medicine, especially in ambulatory surgery and enhanced recovery after surgery (ARS). The group also invests more than €200 million every year in its establishments, whether in new surgical and imaging technologies, or in the construction and modernisation of establishments. It also innovates at the service of patients with new digital tools and by developing its organisations to improve the efficiency of care.


Employees

10,000+

Links